{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T10:10:11Z","timestamp":1753438211992,"version":"3.40.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-059B"],"award-info":[{"award-number":["TJYXZDXK-059B"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-97312-9","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T15:51:27Z","timestamp":1744386687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrative transcriptomic and metabolomic analysis explores the mechanisms by which ACT001 treats MAFLD in mice"],"prefix":"10.1038","volume":"15","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingqin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqiang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"97312_CR1","doi-asserted-by":"publisher","unstructured":"Eslam, M., Sanyal, A. J. & George, J. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312 (2020).","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"97312_CR2","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne, C. D. & Targher, G. NAFLD: A multisystem disease. J. Hepatol. 62, S47\u2013S64. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012 (2015).","journal-title":"J. Hepatol."},{"key":"97312_CR3","doi-asserted-by":"publisher","first-page":"103910","DOI":"10.1016\/j.drudis.2024.103910","volume":"29","author":"S Wei","year":"2024","unstructured":"Wei, S., Wang, L., Evans, P. C. & Xu, S. NAFLD and NASH: Etiology, targets and emerging therapies. Drug Discov. Today 29, 103910. https:\/\/doi.org\/10.1016\/j.drudis.2024.103910 (2024).","journal-title":"Drug Discov. Today"},{"key":"97312_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","volume":"79","author":"AM Allen","year":"2023","unstructured":"Allen, A. M., Lazarus, J. V. & Younossi, Z. M. Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties. J. Hepatol. 79, 209\u2013217. https:\/\/doi.org\/10.1016\/j.jhep.2023.01.026 (2023).","journal-title":"J. Hepatol."},{"key":"97312_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12964-022-00862-y","volume":"20","author":"L Cai","year":"2022","unstructured":"Cai, L. et al. ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT\/NF\u03baB\/NLRP3 pathway. Cell. Commun. Signal. 20, 56. https:\/\/doi.org\/10.1186\/s12964-022-00862-y (2022).","journal-title":"Cell. Commun. Signal."},{"key":"97312_CR6","doi-asserted-by":"publisher","first-page":"114808","DOI":"10.1016\/j.biopha.2023.114808","volume":"163","author":"H Luo","year":"2023","unstructured":"Luo, H. et al. ACT001 ameliorates ionizing radiation-induced lung injury by inhibiting NLRP3 inflammasome pathway. Biomed. Pharmacother. 163, 114808. https:\/\/doi.org\/10.1016\/j.biopha.2023.114808 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"97312_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12944-023-01949-2","volume":"22","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. ACT001 alleviates chronic kidney injury induced by a high-fat diet in mice through the GPR43\/AMPK pathway. Lipids Health Dis. 22, 198. https:\/\/doi.org\/10.1186\/s12944-023-01949-2 (2023).","journal-title":"Lipids Health Dis."},{"key":"97312_CR8","doi-asserted-by":"publisher","first-page":"176529","DOI":"10.1016\/j.ejphar.2024.176529","volume":"971","author":"Q Yu","year":"2024","unstructured":"Yu, Q. et al. Alleviative effects of the parthenolide derivative ACT001 on insulin resistance induced by sodium propionate combined with a high-fat diet and its potential mechanisms. Eur. J. Pharmacol. 971, 176529. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176529 (2024).","journal-title":"Eur. J. Pharmacol."},{"key":"97312_CR9","doi-asserted-by":"publisher","first-page":"11336","DOI":"10.1038\/s41598-023-38448-4","volume":"13","author":"H Zhou","year":"2023","unstructured":"Zhou, H. et al. iTRAQ-based quantitative proteomics analysis of the effect of ACT001 on non-alcoholic steatohepatitis in mice. Sci. Rep. 13, 11336. https:\/\/doi.org\/10.1038\/s41598-023-38448-4 (2023).","journal-title":"Sci. Rep."},{"key":"97312_CR10","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"97312_CR11","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"97312_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"97312_CR13","doi-asserted-by":"publisher","unstructured":"Guo, X., Yin, X., Liu, Z. & Wang, J. Non-Alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. Int. J. Mol. Sci. 23. https:\/\/doi.org\/10.3390\/ijms232415489 (2022).","DOI":"10.3390\/ijms232415489"},{"key":"97312_CR14","doi-asserted-by":"publisher","unstructured":"Cai, J. et al. The metabolic pathway of bile secretion is vulnerable to Salmonella enterica exposure in Porcine intestinal epithelial cells. Animals 14. https:\/\/doi.org\/10.3390\/ani14050789 (2024).","DOI":"10.3390\/ani14050789"},{"key":"97312_CR15","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.cca.2010.08.003","volume":"411","author":"AHM Smelt","year":"2010","unstructured":"Smelt, A. H. M. Triglycerides and gallstone formation. Clin. Chim. Acta 411, 1625\u20131631. https:\/\/doi.org\/10.1016\/j.cca.2010.08.003 (2010).","journal-title":"Clin. Chim. Acta"},{"key":"97312_CR16","doi-asserted-by":"publisher","unstructured":"Gottlieb, A. & Canbay, A. Why bile acids are so important in Non-Alcoholic fatty liver disease (NAFLD) progression. Cells 8. https:\/\/doi.org\/10.3390\/cells8111358 (2019).","DOI":"10.3390\/cells8111358"},{"key":"97312_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/hep.28709","volume":"65","author":"JP Arab","year":"2017","unstructured":"Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M. & Trauner, M. Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Hepatology 65, 350\u2013362. https:\/\/doi.org\/10.1002\/hep.28709 (2017).","journal-title":"Hepatology"},{"key":"97312_CR18","doi-asserted-by":"publisher","first-page":"104243","DOI":"10.1016\/j.etap.2023.104243","volume":"102","author":"K Abass","year":"2023","unstructured":"Abass, K., Reponen, P., Anyanwu, B. & Pelkonen, O. Inter-species differences between humans and other mammals in the in vitro metabolism of Carbofuran and the role of human CYP enzymes. Environ. Toxicol. Pharmacol. 102, 104243. https:\/\/doi.org\/10.1016\/j.etap.2023.104243 (2023).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"97312_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.etap.2016.05.014","volume":"45","author":"C Wang","year":"2016","unstructured":"Wang, C., Tao, Q., Wang, X., Wang, X. & Zhang, X. Impact of high-fat diet on liver genes expression profiles in mice model of nonalcoholic fatty liver disease. Environ. Toxicol. Pharmacol. 45, 52\u201362. https:\/\/doi.org\/10.1016\/j.etap.2016.05.014 (2016).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"97312_CR20","doi-asserted-by":"publisher","first-page":"1157200","DOI":"10.3389\/fphar.2023.1157200","volume":"14","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis through modulating multiple pathways in mice. Front. Pharmacol. 14, 1157200. https:\/\/doi.org\/10.3389\/fphar.2023.1157200 (2023).","journal-title":"Front. Pharmacol."},{"key":"97312_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.plefa.2008.09.019","volume":"79","author":"KL Fritsche","year":"2008","unstructured":"Fritsche, K. L. Too much Linoleic acid promotes inflammation-doesn\u2019t it? Prostaglandins Leukot. Essent. Fat. Acids 79, 173\u2013175. https:\/\/doi.org\/10.1016\/j.plefa.2008.09.019 (2008).","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"97312_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plefa.2018.05.004","volume":"135","author":"JL Burns","year":"2018","unstructured":"Burns, J. L., Nakamura, M. T. & Ma, D. W. L. Differentiating the biological effects of Linoleic acid from arachidonic acid in health and disease. Prostaglandins Leukot. Essent. Fat. Acids 135, 1\u20134. https:\/\/doi.org\/10.1016\/j.plefa.2018.05.004 (2018).","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"97312_CR23","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","volume":"46","author":"P Puri","year":"2007","unstructured":"Puri, P. et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46, 1081\u20131090 (2007).","journal-title":"Hepatology"},{"key":"97312_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fphar.2014.00196","volume":"5","author":"K Aquilano","year":"2014","unstructured":"Aquilano, K., Baldelli, S. & Ciriolo, M. R. Glutathione: New roles in redox signaling for an old antioxidant. Front. Pharmacol. 5, 196. https:\/\/doi.org\/10.3389\/fphar.2014.00196 (2014).","journal-title":"Front. Pharmacol."},{"key":"97312_CR25","doi-asserted-by":"publisher","first-page":"111093","DOI":"10.1016\/j.cbi.2024.111093","volume":"398","author":"SH Hong","year":"2024","unstructured":"Hong, S. H., Yu, X., Zhu, Y. & Chen, Y. Liver epigenomic signature associated with chronic oxidative stress in a mouse model of glutathione deficiency. Chem. Biol. Interact. 398, 111093. https:\/\/doi.org\/10.1016\/j.cbi.2024.111093 (2024).","journal-title":"Chem. Biol. Interact."},{"key":"97312_CR26","doi-asserted-by":"publisher","first-page":"13465","DOI":"10.1096\/fj.201901038RR","volume":"33","author":"A Allawzi","year":"2019","unstructured":"Allawzi, A. et al. Redistribution of EC-SOD resolves bleomycin-induced inflammation via increased apoptosis of recruited alveolar macrophages. FASEB J. 33, 13465\u201313475. https:\/\/doi.org\/10.1096\/fj.201901038RR (2019).","journal-title":"FASEB J."},{"key":"97312_CR27","doi-asserted-by":"publisher","first-page":"1147414","DOI":"10.3389\/fphar.2023.1147414","volume":"14","author":"J Pei","year":"2023","unstructured":"Pei, J., Pan, X., Wei, G. & Hua, Y. Research progress of glutathione peroxidase family (GPX) in redoxidation. Front. Pharmacol. 14, 1147414. https:\/\/doi.org\/10.3389\/fphar.2023.1147414 (2023).","journal-title":"Front. Pharmacol."},{"key":"97312_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1177\/0960327116650013","volume":"36","author":"YC Chang","year":"2017","unstructured":"Chang, Y. C. et al. Glutathione S-transferase A1\u2014a sensitive marker of alcoholic injury on primary hepatocytes. Hum. Exp. Toxicol. 36, 386\u2013394. https:\/\/doi.org\/10.1177\/0960327116650013 (2017).","journal-title":"Hum. Exp. Toxicol."},{"key":"97312_CR29","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.3892\/etm.2017.4957","volume":"14","author":"X Ma","year":"2017","unstructured":"Ma, X. et al. Expression of glutathione S-transferase A1, a phase II drug-metabolizing enzyme in acute hepatic injury on mice. Exp. Ther. Med. 14, 3798\u20133804. https:\/\/doi.org\/10.3892\/etm.2017.4957 (2017).","journal-title":"Exp. Ther. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97312-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97312-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97312-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T15:51:28Z","timestamp":1744386688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97312-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97312"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97312-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the ARRIVE guidelines and was approved by the Ethics Committee of Nankai University (Approval No. 2021-SYDWLL-000003).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"12494"}}